Summary
- Current Price
- As of today, GILD price is $148.95, up +3.60% on
- Current Price All-Time High
- GILD price is currently -5.30% below its historical high of $157.29 set on
- Market Cap
- GILD current market cap is $185B, up +29.85% over the past 365 days
- PE Ratio
- GILD current PE ratio is 21.96
- Revenue
- GILD current annual revenue is $29.45B, up +2.51% year-over-year
- Next Earnings
- The next earnings release for GILD is on
Profile
| Metric | Value |
|---|---|
| Full Name | Gilead Sciences, Inc. |
| Ticker | NASDAQ: GILD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | gilead.com |
| Employees | 17,600 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $148.95 | |
| Price, 1D Change | +3.60% | |
| Market Cap | $185B | |
| TTM Dividend Yield | 2.12% | |
| PE Ratio | 21.96 | |
| Beta | 0.38 | |
| Revenue | $29B | |
| Revenue, 1Y Change | +2.51% | |
| EPS | $6.78 | |
| EPS, 1Y Change | +1,672.78% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.79 | |
| Next Ex-Dividend | $0.82 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $6.78 | |
| EPS Estimate | N/A | $8.68 |
| EPS Est. Change | N/A | +28.05% |
| Revenue | $29.45B | |
| Revenue Estimate | N/A | $30.19B |
| Revenue Est. Change | N/A | +2.51% |
| Current Price | $148.95 | |
| Price Target | - | $160.00 |
| Price Tgt. Change | - | +7.42% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.41 | $0.38 | -91.32% | |
| $8.12 | $6.78 | -16.47% | |
| $8.68 | N/A | +28.05% | |
| $9.67 | N/A | +42.53% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $28.30B | $28.73B | +1.49% | |
| $29.20B | $29.45B | +0.84% | |
| $30.19B | N/A | +2.51% | |
| $32.01B | N/A | +8.71% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +30.30% | |
| Price, 3Y | +87.08% | |
| Market Cap, 1Y | +29.85% | |
| Market Cap, 3Y | +86.22% | |
| Revenue, 1Y | +2.51% | |
| Revenue, 3Y | +8.72% | |
| EPS, 1Y | +1,672.78% | |
| EPS, 3Y | +86.36% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $148.95 | |
| SMA 200 | $120.13 | |
| SMA 200 vs Price | -19.35% | |
| SMA 50 | $135.25 | |
| SMA 50 vs Price | -9.20% | |
| Beta | 0.38 | |
| ATR | $4.04 | |
| 14-Day RSI | 56.66 | |
| 10-Day Volatility | 28.70% | |
| 1-Year Volatility | 29.06% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.79 | |
| Upcoming | $0.82 | |
| Dividend Yield | 2.12% | |
| Total Dividend | $3.16 | |
| Dividends Paid | $4.00B | |
| Payout Ratio | 47.04% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $29.45B | |
| EPS | $6.78 | |
| Gross Profit | $25.52B | |
| Gross Margin | 78.84% | |
| Operating Profit | $11.82B | |
| Operating Margin | 40.14% | |
| Net Income | $8.51B | |
| Net Margin | 28.90% | |
| EBITDA | $14.58B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| Current Ratio | 1.68 | |
| Quick Ratio | 1.53 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 4.70 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 21.96 | |
| PS Ratio | 6.28 | |
| PB Ratio | 8.14 | |
| EV/EBITDA | 13.79 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $22.62B | |
| Cash & Equivalents | $10.61B | |
| Total Assets | $59.02B | |
| Current Assets | $19.89B | |
| Total Liabilities | $36.40B | |
| Current Liabilities | $11.81B | |
| Total Debt | $25.54B | |
| Short Term Debt | $2.91B | |
| Accounts Payable | $715.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $20.93B | |
| Operating Expenses | $13.71B | |
| Cost Of Goods Sold | $3.92B | |
| SG&A | $0.00 | |
| D&A | $2.76B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.29B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $10.02B | |
| CFI | -$4.79B | |
| CFF | -$7.75B | |
| Capex | $563.00M | |
| Free Cash Flow | $10.02B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Needham | → | |
| Barclays | ||
| Wells Fargo | → | |
| Truist Securities | → | |
| Scotiabank | → | |
| RBC Capital | → | |
| Needham | → | |
| Cantor Fitzgerald | → | |
| Truist Securities | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with GILD
FAQ
What is the ticker symbol for Gilead Sciences, Inc.?
The ticker symbol for Gilead Sciences, Inc. is NASDAQ:GILD
Does Gilead Sciences, Inc. pay dividends?
Yes, Gilead Sciences, Inc. pays dividends. The last payment was $0.79, with an ex-dividend date on December 14, 2025
What sector is Gilead Sciences, Inc. in?
Gilead Sciences, Inc. is in the Healthcare sector
What industry is Gilead Sciences, Inc. in?
Gilead Sciences, Inc. is in the General Drug Manufacturers industry
What country is Gilead Sciences, Inc. based in?
Gilead Sciences, Inc. is headquartered in United States
When did Gilead Sciences, Inc. go public?
Gilead Sciences, Inc. initial public offering (IPO) was on January 22, 1992
Is Gilead Sciences, Inc. in the S&P 500?
Yes, Gilead Sciences, Inc. is included in the S&P 500 index
Is Gilead Sciences, Inc. in the NASDAQ 100?
Yes, Gilead Sciences, Inc. is included in the NASDAQ 100 index
Is Gilead Sciences, Inc. in the Dow Jones?
No, Gilead Sciences, Inc. is not included in the Dow Jones index
When was Gilead Sciences, Inc. last earnings report?
Gilead Sciences, Inc.'s most recent earnings report was on February 10, 2026
When does Gilead Sciences, Inc. report earnings?
The next expected earnings date for Gilead Sciences, Inc. is April 23, 2026
Data Sources & References
- GILD Official Website www.gilead.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
- GILD Profile on Yahoo Finance finance.yahoo.com/quote/GILD
- GILD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gild
